Related Experiment Video
Updated: May 3, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin
J Ambrosioni1, A Mamin, A Hadengue
1Virology Laboratory, Infectious Diseases Service, University Hospitals of Geneva, Geneva, Switzerland.
Abstract:
Hepatitis E virus (HEV) can cause chronic infections in immunocompromised hosts. Viral kinetics in plasma and stools are poorly understood, particularly during antiviral treatment. Prolonged faecal shedding may be a concern for transmission. We describe HEV kinetics in an immunocompromised patient with prolonged faecal shedding despite undetectable viraemia on ribavirin treatment.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

